ZA200110240B - Enhanced wound coverage to enhance wound healing. - Google Patents

Enhanced wound coverage to enhance wound healing.

Info

Publication number
ZA200110240B
ZA200110240B ZA200110240A ZA200110240A ZA200110240B ZA 200110240 B ZA200110240 B ZA 200110240B ZA 200110240 A ZA200110240 A ZA 200110240A ZA 200110240 A ZA200110240 A ZA 200110240A ZA 200110240 B ZA200110240 B ZA 200110240B
Authority
ZA
South Africa
Prior art keywords
wound
coverage
enhanced
enhance
wound healing
Prior art date
Application number
ZA200110240A
Other languages
English (en)
Inventor
David N Herndon
Jose R Perez-Polo
Robert E Barrow
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of ZA200110240B publication Critical patent/ZA200110240B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
ZA200110240A 1999-06-22 2001-12-13 Enhanced wound coverage to enhance wound healing. ZA200110240B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14019699P 1999-06-22 1999-06-22

Publications (1)

Publication Number Publication Date
ZA200110240B true ZA200110240B (en) 2003-05-28

Family

ID=22490162

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200110240A ZA200110240B (en) 1999-06-22 2001-12-13 Enhanced wound coverage to enhance wound healing.

Country Status (12)

Country Link
US (2) US6576618B1 (ru)
EP (1) EP1210046A4 (ru)
JP (1) JP2003502350A (ru)
CN (1) CN1137723C (ru)
AU (1) AU771904B2 (ru)
BR (1) BR0012528A (ru)
CA (1) CA2377371A1 (ru)
IL (1) IL147127A0 (ru)
MX (1) MXPA02000128A (ru)
RU (1) RU2245722C2 (ru)
WO (1) WO2000078259A1 (ru)
ZA (1) ZA200110240B (ru)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02000128A (es) * 1999-06-22 2002-06-21 Res Dev Foundation Material mejorado de heridas para mejorar curacion de heridas.
EP1391214A4 (en) 2001-05-09 2006-05-17 Anges Mg Inc GM TRANSFER OF ANGIOGENIC FACTOR IN SKIN DISEASES
DE10214260A1 (de) * 2002-03-30 2003-10-23 Wolfgang Richter Liposomaler Polynucleotidsequenzkomplex zur topischen Applikation auf Körperoberflächen oder systemischen Verabreichung für die medizinische oder kosmetische Anwendung
JP4728807B2 (ja) * 2003-09-03 2011-07-20 敏一 中村 ヒト組換えｈｇｆを含有する皮膚潰瘍予防治癒剤
GB2423934B (en) * 2003-09-04 2007-11-28 Cook Biotech Inc Extracellular matrix composite materials, and manufacture and use thereof
US8276091B2 (en) * 2003-09-16 2012-09-25 Ram Consulting Haptic response system and method of use
EP1634877B1 (en) * 2004-08-17 2011-06-22 Simpson Biotech Co., Ltd. Mixture and compounds from mycelia of antrodia camphorata and use thereof
EP1863545B1 (en) * 2005-03-19 2015-11-18 Cook Biotech, Inc. Prosthetic implants including ECM composite material
CA2602684C (en) * 2005-03-31 2014-07-22 Stemnion, Inc. Amnion-derived cell compositions, methods of making and uses thereof
CN1853609B (zh) * 2005-04-25 2010-05-12 邱英明 酸性纤维母细胞生长因子（fgf-1）应用于护肤功效
US8778362B2 (en) 2005-10-27 2014-07-15 University Of Notre Dame Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof
GB0611405D0 (en) * 2006-06-09 2006-07-19 Univ Belfast FKBP-L: A novel inhibitor of angiogenesis
US8372437B2 (en) 2006-08-17 2013-02-12 Mimedx Group, Inc. Placental tissue grafts
EP2079490B1 (en) * 2006-10-23 2012-08-29 Cook Biotech Incorporated Processed ecm materials with enhanced component profiles
BRPI0810949A2 (pt) 2007-05-29 2015-10-27 Christopher B Reid "método de preparação de células multipotentes, auto-renovadoras, diferenciadoras ou resistentes a doenças, célula e vetor pra uso do método"
US8357403B2 (en) 2007-09-07 2013-01-22 Mimedx Group, Inc. Placental tissue grafts
US10500309B2 (en) * 2007-10-05 2019-12-10 Cook Biotech Incorporated Absorbable adhesives and their formulation for use in medical applications
US20100008965A1 (en) * 2008-04-01 2010-01-14 Pavalko Fredrick M Biocompatible medical products having enhanced anti-thrombogenic properties
US9480549B2 (en) 2008-04-25 2016-11-01 Allosource Multi-layer tissue patches
US20110129520A1 (en) * 2008-04-25 2011-06-02 Simon Bogdansky Anti-Adhesion Barrier Wound Dressing Comprising Processed Amniotic Tissue and Method of Use
US9358320B2 (en) 2008-04-25 2016-06-07 Allosource Multi-layer tissue patches
JP2011526811A (ja) * 2008-07-01 2011-10-20 クック・バイオテック・インコーポレイテッド 漿膜下筋膜を含む分離された細胞外マトリクス材料
WO2011008904A1 (en) 2009-07-17 2011-01-20 Tabor Aaron T Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
WO2011031827A2 (en) 2009-09-09 2011-03-17 Cook Biotech Incorporated Manufacture of extracellular matrix products using supercritical or near supercritical fluids
US10279007B2 (en) 2010-11-15 2019-05-07 Oxygenetix Institute, Inc. Topical treatment method for healing wounds, disinfecting, covering and concealing the wound until healing occurs
CA2900851C (en) 2013-03-15 2021-06-22 Michelle CHUTKA Ecm implant compositions and methods
CN105536031B (zh) * 2016-02-03 2018-12-11 浙江康诚工业产品设计有限公司 一种茶树油脂质体抗炎抑菌医用敷料的制备方法
EP4188465A1 (en) 2020-07-27 2023-06-07 Cook Biotech Incorporated Adhesive for surgical staple line reinforcement

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361552A (en) * 1980-09-26 1982-11-30 Board Of Regents, The University Of Texas System Wound dressing
ATE85080T1 (de) * 1984-02-17 1993-02-15 Genentech Inc Menschlicher transformationswachstumsfaktor und vorlaeufer oder fragment hiervon, zellen, dna, vektoren und verfahren zu ihrer herstellung, zusammensetzungen und produkte, die diese enthalten, sowie davon abgeleitete antikoerper und diagnostizierverfahren.
US4897355A (en) * 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
GB8708009D0 (en) * 1987-04-03 1987-05-07 Clayton Found Res Injectable soft tissue augmentation materials
US5976878A (en) * 1987-04-28 1999-11-02 The Regents Of The University Of California Method and apparatus for preparing composite skin replacement
NZ226170A (en) * 1987-09-18 1990-07-26 Ethicon Inc Stable freeze-dried pharmaceutical composition containing epidermal growth factor
US5256644A (en) * 1988-05-20 1993-10-26 Institute Of Molecular Biology, Inc. Wound healing using IGF-II and TGF
US5064655A (en) * 1989-02-24 1991-11-12 Liposome Technology, Inc. Liposome gel composition and method
US6559119B1 (en) * 1990-11-27 2003-05-06 Loyola University Of Chicago Method of preparing a tissue sealant-treated biomedical material
EP0489206B1 (en) * 1990-12-04 1997-02-19 Zenith Technology Corporation Limited Synthetic skin substitutes
US5265644A (en) * 1992-06-02 1993-11-30 Walbro Corporation Fuel pressure regulator
CA2139757C (en) * 1992-07-08 2009-04-14 Gunther Maierhofer Liposomes, method of preparing the same and use thereof in the preparation of drugs
ATE241340T1 (de) * 1994-02-17 2003-06-15 New York Blood Ct Inc Biologische bioadhäsive präparate, die fibrinkleber und liposomen enthalten, verfahren für ihre herstellung und verwendung
US5962427A (en) * 1994-02-18 1999-10-05 The Regent Of The University Of Michigan In vivo gene transfer methods for wound healing
US5728546A (en) * 1995-06-05 1998-03-17 Human Genome Sciences, Inc. Fibroblast growth factor 13
US6139819A (en) * 1995-06-07 2000-10-31 Imarx Pharmaceutical Corp. Targeted contrast agents for diagnostic and therapeutic use
US6248722B1 (en) * 1995-08-29 2001-06-19 Sumitomo Pharmaceuticals Company, Limited Medicament comprising HGF gene
US6132765A (en) * 1996-04-12 2000-10-17 Uroteq Inc. Drug delivery via therapeutic hydrogels
US6143037A (en) * 1996-06-12 2000-11-07 The Regents Of The University Of Michigan Compositions and methods for coating medical devices
US6252129B1 (en) * 1996-07-23 2001-06-26 Electrosols, Ltd. Dispensing device and method for forming material
US5741509A (en) * 1996-08-26 1998-04-21 Alvin S. Berlat Silicone wound dressing
US6153631A (en) * 1996-10-23 2000-11-28 Zymogenetics, Inc. Compositions and methods for treating bone deficit conditions
EP0943003B1 (en) * 1996-12-02 2004-11-17 Valentis Inc. Insulin-like growth factor i (igf-i) expression system and methods of use
US6034072A (en) * 1997-02-10 2000-03-07 Genemedicine, Inc. IL-2 gene expression and delivery systems and uses
US5837283A (en) * 1997-03-12 1998-11-17 The Regents Of The University Of California Cationic lipid compositions targeting angiogenic endothelial cells
EP1027033B1 (en) * 1997-05-14 2009-07-22 The University Of British Columbia High efficiency encapsulation of nucleic acids in lipid vesicles
US6060590A (en) * 1998-03-31 2000-05-09 The Regents Of The University Of California Chitinase related proteins and methods of use
IL139030A0 (en) * 1998-04-17 2001-11-25 Angiogenix Inc Therapeutic angiogenic factors and methods for their use
US20010056073A1 (en) * 1998-07-21 2001-12-27 Ascher Shmulewitz Gene therapy method for revascularizing ischemic tissue
MXPA02000128A (es) * 1999-06-22 2002-06-21 Res Dev Foundation Material mejorado de heridas para mejorar curacion de heridas.

Also Published As

Publication number Publication date
CA2377371A1 (en) 2000-12-28
WO2000078259A1 (en) 2000-12-28
CN1372450A (zh) 2002-10-02
CN1137723C (zh) 2004-02-11
IL147127A0 (en) 2002-08-14
US6576618B1 (en) 2003-06-10
MXPA02000128A (es) 2002-06-21
AU5758500A (en) 2001-01-09
AU771904B2 (en) 2004-04-08
US20020128222A1 (en) 2002-09-12
EP1210046A4 (en) 2007-05-02
RU2245722C2 (ru) 2005-02-10
EP1210046A1 (en) 2002-06-05
BR0012528A (pt) 2002-04-09
JP2003502350A (ja) 2003-01-21

Similar Documents

Publication Publication Date Title
ZA200110240B (en) Enhanced wound coverage to enhance wound healing.
GB9930570D0 (en) Therapy
GB9918760D0 (en) Topical treatment
ZA200108489B (en) Tampon.
GB9907243D0 (en) Therapy
ZA200109206B (en) Preparation of substituted piperidin-4-ones.
AU140293S (en) Secateurs
GB0030217D0 (en) Structure
HK1048307A1 (zh) 取代的雜環基-2h-苯並吡喃類化合物
GB9903804D0 (en) Pluripotential cells-2
GB9914798D0 (en) Ensure
GB9911456D0 (en) Oligohydroxyl substituted 3-urea-benzofurane-and-pyridofurane-derivatives
GB9926080D0 (en) Structure
EP1170007A4 (en) DRUGS
PL352101A1 (en) Substituted phenylcyclohexanocarboxyamides
TW395234U (en) Controllable stanch band structure
TW384889U (en) Combination truss
TW458186U (en) Improved form structure
GB9924664D0 (en) Topical treatment assembly
TW439826U (en) Quick-assembled form structure
GB9907193D0 (en) Compression bandage
TW417464U (en) Improved cloth-hanger structure
TW401796U (en) Improved cupware structure
TW390272U (en) Improved wave-maker structure
TW411027U (en) Improved mini-button structure